U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C32H58N8O8S.5ClH
Molecular Weight 897.221
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CABIOTRAXETAN PENTAHYDROCHLORIDE

SMILES

Cl.Cl.Cl.Cl.Cl.[H][C@@]2(CCCCCNCCCCCCNC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1)SC[C@]3([H])NC(=O)N[C@]23[H]

InChI

InChIKey=CGNNWHZLCOLNDQ-VKGQBVRDSA-N
InChI=1S/C32H58N8O8S.5ClH/c41-27(34-11-7-2-1-5-9-33-10-6-3-4-8-26-31-25(24-49-26)35-32(48)36-31)20-37-12-14-38(21-28(42)43)16-18-40(23-30(46)47)19-17-39(15-13-37)22-29(44)45;;;;;/h25-26,31,33H,1-24H2,(H,34,41)(H,42,43)(H,44,45)(H,46,47)(H2,35,36,48);5*1H/t25-,26-,31-;;;;;/m0...../s1

HIDE SMILES / InChI

Molecular Formula C32H58N8O8S
Molecular Weight 714.917
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

PubMed

PubMed

TitleDatePubMed
A new biotin derivative-DOTA conjugate as a candidate for pretargeted diagnosis and therapy of tumors.
2003 Jul 3
Patents

Sample Use Guides

Different molar ratios of 90Y-labeled r-BHD toward Av were studied. The same amount of radiolabeled r-BHD (1 µg) was reacted with decreasing amounts of Av (Mw 66 kDa), to obtain 1:2, 1:4, 1:8, 1:16, and 1:32 Av/rBHD molar ratios. The mixtures were incubated at 37 °C and analyzed at 2 and 24 h using Centricon YM-10 concentrators (Millipore, Bedford, MA, 10kDa Mw cutoff). Aliquots from the top and bottom parts of the Centricon were counted in the â-counter as previously described. To evaluate the activity a specifically bound to the Centricon, an 90Y-labeled r-BHD aliquot was centrifuged without adding Av.
Substance Class Chemical
Created
by admin
on Sat Dec 16 18:21:59 GMT 2023
Edited
by admin
on Sat Dec 16 18:21:59 GMT 2023
Record UNII
T8Q93U63AG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CABIOTRAXETAN PENTAHYDROCHLORIDE
Common Name English
1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, 10-(2-((6-((5-((3AS,4S,6AR)-HEXAHYDRO-2-OXO-1H-THIENO(3,4-D)IMIDAZOL-4-YL)PENTYL)AMINO)HEXYL)AMINO)-2-OXOETHYL)-, PENTAHYDROCHLORIDE
Systematic Name English
1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, 10-(2-((6-((5-((3AS,4S,6AR)-HEXAHYDRO-2-OXO-1H-THIENO(3,4-D)IMIDAZOL-4-YL)PENTYL)AMINO)HEXYL)AMINO)-2-OXOETHYL)-, HYDROCHLORIDE (1:5)
Systematic Name English
Code System Code Type Description
FDA UNII
T8Q93U63AG
Created by admin on Sat Dec 16 18:22:00 GMT 2023 , Edited by admin on Sat Dec 16 18:22:00 GMT 2023
PRIMARY
CAS
876274-56-5
Created by admin on Sat Dec 16 18:22:00 GMT 2023 , Edited by admin on Sat Dec 16 18:22:00 GMT 2023
PRIMARY
PUBCHEM
140177109
Created by admin on Sat Dec 16 18:22:00 GMT 2023 , Edited by admin on Sat Dec 16 18:22:00 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY